🧬 — Gonorrhea
🧬 Gonorrhea is a bacterial sexually transmitted infection routinely screened for at the first prenatal visit because of its significant maternal and neonatal risks.
🧬 In pregnancy, untreated gonorrhea increases the risk of preterm labor, premature rupture of membranes, and chorioamnionitis.
🧬 Neonates exposed during delivery are at risk for ophthalmia neonatorum, which can lead to blindness if not promptly treated.
🧬 Early identification allows for timely antibiotic therapy, reducing complications for both the mother and the newborn.
🧬 — Syphilis
🧬 Syphilis screening is mandatory in early pregnancy due to the severe and preventable outcomes associated with untreated infection.
🧬 Maternal syphilis can cross the placenta, resulting in congenital syphilis, stillbirth, neonatal death, or severe lifelong disabilities.
🧬 Screening early allows treatment with penicillin, which is highly effective in preventing fetal transmission.
🧬 Because syphilis may be asymptomatic, routine screening is essential even in clients without symptoms.
🧬— Chlamydia
🧬 Chlamydia is one of the most common bacterial STIs and is included in initial prenatal screening, particularly in clients younger than 25 or those at increased risk.
🧬 Untreated chlamydia is associated with preterm birth, low birth weight, and postpartum infections.
🧬 Neonates exposed to chlamydia may develop conjunctivitis or pneumonia, often presenting weeks after birth.
🧬 Early detection and treatment protect maternal reproductive health and significantly reduce neonatal complications.
❌— Candidiasis
❌ Candidiasis is a fungal infection, not a bacterial STI.
❌ It is diagnosed based on symptoms and examination, not routine prenatal STI screening.
❌— Trichomoniasis
❌ Trichomoniasis is caused by a protozoan parasite, not bacteria.
❌ It is not part of the standard initial bacterial STI screening panel.